# 2026-08585: Pharma Firm Seeks Bulk GHB Okay for Legit Medicines

2026-08585, Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-05-04, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 6, 2026. Such persons may also file a written request for a hearing on the application on or before July 6, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-08585
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08585
- Title: Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 24009
- Published: 2026-05-04
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 6, 2026. Such persons may also file a written request for a hearing on the application on or before July 6, 2026.
- Comments close: 2026-07-06
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Pharma Firm Seeks Bulk GHB Okay for Legit Medicines

## Summary

Patheon Pharmaceuticals wants to make a big batch of a controlled drug called Gamma Hydroxybutyric Acid (GHB) to help create FDA-approved medicines. People and companies involved with controlled substances can share their thoughts or ask for a hearing by July 6, 2026. This move could speed up medicine production but also means careful government checks and rules.

## Abstract

Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-08585 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/04/2026-08585/bulk-manufacturer-of-controlled-substances-application-patheon-pharmaceuticals-inc)
- [2026-08585 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-04/pdf/2026-08585.pdf)

## Related
- [Previous: 2026-08584, Submission for Office of Management and Budget Review; Safe Access for Victims'…](https://policyrisk.com/federal-register/2026-08584)
- [Next: 2026-08586, Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.](https://policyrisk.com/federal-register/2026-08586)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08585 (as of 2026-06-08).
